SynAct Pharma Names James Knight as Chief Business Officer - Already published in Swedish today 2021-02-11
SynAct carries out a directed share issue and raises proceeds of SEK 80 million - English version - Swedish version published 08:00 today 2021-02-05
SynAct explores the conditions for carrying out a directed share issue - English version - Published today 17.31 CET 2021-02-04
SynAct Pharma prepares move to Nasdaq Stockholm - English version - Published today at 17.31 CET 2021-02-04
Pressmeddelande 4 februari 2021, 17:31Pressmeddelande 4 februari 2021, 17:31 SynAct utreder förutsättningarna för att genomföra en riktad nyemission 2021-02-04